These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 6821032)

  • 41. Importation into the UK of a strain of Neisseria gonorrhoeae resistant to penicillin, ciprofloxacin and tetracycline.
    Turner A; Gough KR; Jephcott AE; McClean AN
    Genitourin Med; 1995 Oct; 71(5):331-2. PubMed ID: 7490059
    [No Abstract]   [Full Text] [Related]  

  • 42. Use of gonococcal W serogrouping in the evaluation of a clinical trial of rosoxacin.
    Rudén AK; Werner YK; Ringertz O; Bygdeman SM; Bäckman M; Sandström EG
    Sex Transm Dis; 1985; 12(1):19-24. PubMed ID: 3890225
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasmid-mediated antimicrobial resistance in Neisseria gonorrhoeae--United States, 1988 and 1989.
    Centers for Disease Control (CDC)
    MMWR Morb Mortal Wkly Rep; 1990 May; 39(17):284-7, 293. PubMed ID: 2139166
    [No Abstract]   [Full Text] [Related]  

  • 44. The Gonococcal Antimicrobial Surveillance Programme (GASP). WHO western Pacific region, 1995.
    Wkly Epidemiol Rec; 1997 Jan; 72(5):25-7. PubMed ID: 9030034
    [No Abstract]   [Full Text] [Related]  

  • 45. Sensitivity pattern and beta-lactamase screening of Neisseria gonorrhoeae strains isolated in Zaria, Northern Nigeria.
    Joshi RM; Lawande RV
    Trop Geogr Med; 1985 Mar; 37(1):74-6. PubMed ID: 3925605
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Acrosoxacin-resistant gonococci.
    Jones C; Cohen L
    Lancet; 1982 Apr; 1(8276):855-6. PubMed ID: 6122085
    [No Abstract]   [Full Text] [Related]  

  • 47. [Gonorrhea caused by fluoroquinolone resistant gonococci].
    Døsen LK; Moi H
    Tidsskr Nor Laegeforen; 1998 Aug; 118(18):2783-5. PubMed ID: 9748808
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Susceptibility of Neisseria gonorrhoeae to pefloxacin.
    Chan KP; Sng EH; Koh ST
    Ann Acad Med Singap; 1987 Oct; 16(4):636-8. PubMed ID: 3128154
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Rising quinolone resistance in Neisseria gonorrhoeae isolates from New Delhi.
    Bhalla P; Vidhani S; Reddy BS; Chowdhry S; Mathur MD
    Indian J Med Res; 2002 Mar; 115():113-7. PubMed ID: 12201175
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Drug-resistant gonorrhea infections in Canada. Plasma-mediated resistance.
    Bull Pan Am Health Organ; 1986; 20(1):72-4. PubMed ID: 3094611
    [No Abstract]   [Full Text] [Related]  

  • 51. Gonococcal resistance: evolving from penicillin, tetracycline to the quinolones in South Africa -- implications for treatment guidelines.
    De Jongh M; Dangor Y; Adam A; Hoosen AA
    Int J STD AIDS; 2007 Oct; 18(10):697-9. PubMed ID: 17945048
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Detection, management and control of antibiotic resistant strains of Neisseria gonorrhoeae.
    Iowa Med; 1987 Sep; 77(9):461-2. PubMed ID: 3117722
    [No Abstract]   [Full Text] [Related]  

  • 53. Treatment of gonorrhea: what effect will antibiotic resistance have in the future?
    Sparling PF
    Sex Transm Dis; 1979; 6(2 Suppl):120-5. PubMed ID: 115098
    [No Abstract]   [Full Text] [Related]  

  • 54. Gonorrhea: diagnostic and therapeutic strategies in the era of resistance to antibiotics.
    Danielsson D
    Semin Dermatol; 1990 Jun; 9(2):109-16. PubMed ID: 2117965
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Insufficient evaluation of acrosoxacin in treating gonorrhoea.
    Sumathipala AH
    Br J Vener Dis; 1984 Oct; 60(5):349-50. PubMed ID: 6386098
    [No Abstract]   [Full Text] [Related]  

  • 56. Fluoroquinolone resistance in Neisseria gonorrhoeae--Colorado and Washington, 1995.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1995 Oct; 44(41):761-4. PubMed ID: 7565558
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Update on the management of gonorrhea in adults in the United States.
    Newman LM; Moran JS; Workowski KA
    Clin Infect Dis; 2007 Apr; 44 Suppl 3():S84-101. PubMed ID: 17342672
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Increasing prevalence of penicillinase-producing Neisseria gonorrhoeae and the emergence of high-level, plasmid-mediated tetracycline resistance among gonococcal isolates in The Gambia.
    Adegbola RA; Sabally S; Corrah T; West B; Mabey D
    Trop Med Int Health; 1997 May; 2(5):428-32. PubMed ID: 9217698
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Be restrictive in the use of quinolone treatment of gonorrhea--the risk of resistance].
    Bygdeman S; Bäckman M; Lidbrink P; Rudén AK; Thalme A
    Lakartidningen; 1990 Aug; 87(32-33):2514. PubMed ID: 2169013
    [No Abstract]   [Full Text] [Related]  

  • 60. [The monitoring of Neisseria gonorrhoeae infection incidence and its resistance in Suceava County].
    Filipiuc S; Nicolae O; Luncă C; Iancu LS
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(4):1238-42. PubMed ID: 20191906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.